Compare ClearPoint Neuro Inc (CLPT) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ClearPoint Neuro Inc vs Novartis AG — how do they compare? ClearPoint Neuro Inc trades at $14.86 (market cap $454.21M), while Novartis AG trades at $152.38 (market cap $295.37B). The key difference: Novartis AG is far larger — about 650.3× ClearPoint Neuro Inc's market cap, and Novartis AG pays a 3.07% dividend while ClearPoint Neuro Inc pays none. Which is the better fit depends on your goals.
| CLPT | NVS | |
|---|---|---|
Market Cap | $454.21M | $295.37B |
Sector | Health | Health |
52-Week High | $29.60 | $168.62 |
52-Week Low | $8.66 | $119.31 |
Enterprise Value | $488.79M | $336.69B |
Dividend Yield | — | 3.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ClearPoint Neuro Inc
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
